Adage Capital Management, L.P. 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-12 09:05 am Sale | 2025-06-30 | 13G | Janux Therapeutics, Inc. JANX | Adage Capital Management, L.P. | 2,525,000 4.270% | -536,750 (-17.53%) | Filing |
| 2025-02-12 09:30 am Purchase | 2024-12-31 | 13G | Janux Therapeutics, Inc. JANX | Adage Capital Management, L.P. | 3,061,750 5.310% | 3,061,750 (New Position) | Filing |